2-P
2-P
2-P
2-P
6-H
ACTIVATION
ERK1 ACTIVATION
ADDITION
CHELERYTHRINE ADDITION
BPAEC
BPAEC
BPAEC
BPAEC
BPAEC
BPAEC
BPAEC
BPAEC
BPAEC PREPARATION
BPAEC-COVERED COVERSLIP
BPAEC
BSA/TB
BACKGROUND ATHEROSCLEROSI
BIORAD CONFOCAL MICROSCOPE
BIOCHEMICAL CHANGE
BIOLOGICAL FUNCTION
CORONARY HEART DISEASE
CORONARY HEART DISEASE
CORONARY HEART DISEASE
CORONARY HEART DISEASE
CORONARY HEART DISEASE
CORONARY HEART DISEASE
CA
CA
CA
CA
CELL-FREE EXTRACT
CONFOCAL MICROSCOPY
PREPARED SLIDE CONFOCAL MICROSCOPY
COVERSLIP
DMSO
EC
EC
EC CYTOSKELETON
EC GROWTH
EC INTERACTION
EC-SPECIFIC INTEGRIN COMPLEX
EXTRACELLULAR SIGNAL REGULATED KINASE
EXTRACELLULAR SIGNAL REGULATED KINASE
ERK1
ERK1
ERK1
ERK1
ERK1
ERK1
ERK1
ERK1
ERK1
ERK1
ERK2
ERK2
GIBCOBRL
HOMEOSTASI
VASCULAR ENDOTHELIUM HOMEOSTASI
IN VIVO STUDY
INDUCTION
ENZYME NITRIC           OXIDE SYNTHASE INDUCTION
INHIBITOR CONCENTRATION
INHIBITOR STUDY PASSAGE
LOW DENSITY LIPOPROTEIN
LDL OXIDATION
LYSATE
MAP KINASE
MITOGEN ACTIVATED PROTEIN KINASE
MITOGEN ACTIVATED PROTEIN KINASE
MAPK PATHWAY
MAPK PHOSPHATASE-1
MINIMAL ESSENTIAL           MEDIUM
MINIMAL ESSENTIAL           MEDIUM
MAPK PHOSPHATASE 1
MODULATION
ENDOTHELIAL CELL SHAPE MODULATION
NP40
ONLY STUDY
PKC
PKC
PLASTIC COVERSLIP
PREPARATION
PREPARED SLIDE
QUANTIFICATION
RELATIVE CHANGE QUANTIFICATION
TOTAL ERK1 RELATIVE CHANGE QUANTIFICATION
QUIN2-AM
RBI/SIGMA
RBI/SIGMA
REPRESENTATIVE
RESTRICTED DETACHMENT
RESVERATROL
RESVERATROL TREATMENT
RESVERATROL TREATMENT
REVERSIBLE CHANGE
ENDOTHELIAL CELL SHAPE REVERSIBLE CHANGE
S/G
SD
SDS-PAGE
SIEMANN
SIGMA
SIGMA
SIGMA
SIGMA
SIGMA
SPECIFIC IMMUNOREACTIVE BAND
STOCK SOLUTION
TB
TB
TB
TB
TB
TRITON X-100
UV RADIATION
ABILITY
ABILITY
BPAEC ABILITY
ACTIN
ACTIN MICROFILAMENT
ACTIN MICROFILAMENT
ACTIN MICROFILAMENT
ACTIN MICROFILAMENT
ACTIN MICROFILAMENT
ACTIN MICROFILAMENT
ACTIVATION
ACTIVATION
ACTIVATION
ERK1 ACTIVATION
MITOGEN ACTIVATED PROTEIN KINASE ACTIVATION
ADDITION
ADDITION
ADDITION
RESVERATROL ADDITION
ADHERED BPAEC
ADHERED BPAEC
ADHESION MOLECULE
AGGREGATION
AGGREGATION
ALCOHOL CONSUMPTION
ALKALINE PHOSPHATASE-CONJUGATED IGG
ANTI-ATHEROSCLEROTIC AGENT
APROTININ
ARTERIAL FLOW
ARTERIAL FLOW CHALLENGE
ARTERIAL FLOW CONDITION
ARTERIAL FLOW CONDITION
ARTERIAL FLOW CONDITION
ATHEROSCLEROTIC PLAQUE
BALLOON CATHETER INJURY
BARRIER PROPERTY
BIOCHEMICAL CHANGE
BIOCHEMICAL PARAMETER
BOVINE SERUM
BUFFER
C-FOS/C-JUN
CACODYLATE
CARDIOPROTECTIVE MECHANISM
CARDIOPROTECTIVE PROPERTY
CELL GROWTH
CELL GROWTH
CELLULAR BLOOD ELEMENT
CELLULAR CHANGE
CELLULAR HETEROGENEITY
CELLULAR PHENOTYPE
CELLULAR PHENOTYPE
CELLULAR PHENOTYPE
CELLULAR PROPERTY
CENTRIFUGATION
CHELERYTHRINE
CHELERYTHRINE
CHELERYTHRINE
CHELERYTHRINE
CHELERYTHRINE
CHELERYTHRINE
CHEMILUMINESCENCE
CHEMOKINE
COBBLESTONE-LIKE APPEARANCE
COLLAGEN
COLLAGEN-INDUCED AGGREGATION RESPONSE
COLLECTIVE EFFECT
RESVERATROL COLLECTIVE EFFECT
COLOR REACTION
CONCENTRATION
RESVERATROL CONCENTRATION
CONCENTRATION
CONCENTRATION
CONCENTRATION
CONCENTRATION
RESVERATROL CONCENTRATION
RESVERATROL CONCENTRATION
CONFOCAL MICROSCOPY
CONFOCAL MICROSCOPY
CONFOCAL MICROSCOPY
CONFOCAL MICROSCOPY FIELD
CONTAINING D-VALINE
CONTRIBUTION
CONTRIBUTOR
CONTROL CELL
CONTROL CELL
CONTROL CELL
CONTROL CELL
CONTROL CELL
COOPERATIVE STIMULATION
RECEPTOR COOPERATIVE STIMULATION
CORONARY HEART DISEASE
COVERSLIP
COVERSLIP
COVERSLIP
COVERSLIP STAINED
COVERSLIP
COVERSLIP
COVERSLIP
COVERSLIP
COVERSLIP
CRITICAL ROLE
CULTURE SUBSTRATUM
CYTOSKELETAL CHANGE
CYTOSKELETAL CHANGE
CYTOSKELETAL REARRANGEMENT
CYTOSKELETON
CYTOSKELETON
DEGENERATION
ENDOTHELIAL CELL MONOLAYER DEGENERATION
DEMONSTRATION
DEMONSTRATION
DIETARY INGREDIENT
DIETARY RESVERATROL
DISTAL MAIN INTRAPULMONARY ARTERY
DUAL SPECIFICITY PHOSPHASE
ENZYME NITRIC           OXIDE SYNTHASE
ENZYME NITRIC           OXIDE SYNTHASE
ENZYME NITRIC           OXIDE SYNTHASE
ENZYME NITRIC           OXIDE SYNTHASE
ENOS EXPRESSION
ENOS EXPRESSION
BIOCHEMICAL CHANGE ENOS EXPRESSION
EFFECTOR
ERK1 EFFECTOR
ELLIPSOIDAL SHAPE
ENDOTHELIAL CELL CYTOSKELETON
ENDOTHELIAL CELL DAMAGE
ENDOTHELIAL CELL INTERACTION
ENDOTHELIAL CELL LINING
ENDOTHELIAL CELL MONOLAYER
ENDOTHELIAL CELL SHAPE
ENDOTHELIAL CELL SHAPE
ENDOTHELIAL CELL SHAPE CHANGE INDUCED
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL INJURY
ENDOTHELIUM
ENDOTHELIUM
ENZYME
NITRIC OXIDE SYNTHASE ENZYME
EPIFLUORESCENT ILLUMINATION ATTACHMENT
ESSENTIAL MEDIUM
ETHANOL
EXCITATION
RHODAMINE-PHALLOIDIN EXCITATION
EXPERIMENTAL CONDITION
EXPERIMENTAL FORMAT
FETAL BOVINE SERUM
FIBRINOGEN
FINAL CONCENTRATION
FIXED
FIXED
FIXED
FLOW CHAMBER SLIT
FLOW RATE
FOCAL CONTACT ADHESION SITE
FOCAL CONTACT
FUNCTIONAL ALTERATION
FUNCTIONAL CHANGE
FUNCTIONAL CHANGE
FUNCTIONAL MICROTUBULE NETWORK
FUNCTIONAL RESPONSIVENESS
GENE EXPRESSION
GLUTARALDEHYDE
GLYCEROL
GROWING EC
GROWTH
GROWTH
GROWTH ARREST
GROWTH INHIBITION
CONTROL CELL GROWTH
H PRIOR
H PRIOR
HORSERADISH PEROXIDASE-CONJUGATED IGG
IMMEDIATE-EARLY RESPONSE GENE PRODUCT
INCREASED ENOS EXPRESSION
INCREASED ENOS EXPRESSION
INDUCTION
INLET VALVE
INTERCELLULAR CONTACT
INTERCELLULAR CONTACT
INTRACELLULAR
INTRACELLULAR
INTRACELLULAR CALCIUM
INTRACELLULAR CALCIUM
INVERSE RELATIONSHIP
INVESTIGATION
KINASE ACTIVITY
KNOB
LAMINAR ARTERIAL
LEUPEPTIN
MM HEPE
MM MG(OAC)
MM DITHIOTHREITOL
MEAN
MECHANISM
MECHANISM
MECHANOSENSITIVE K
MICROCENTRIFUGE
MICROTUBULE NETWORK
MICROTUBULE NETWORK
MICROTUBULE NETWORK
MICROTUBULE
MICROTUBULE
MICROVASCULAR METABOLIC FUNCTION
MIN
MIN
MIN
MIN
MIN
MIN
MIN
MIN
MIN
MIN
MIN
MIN
MIN
MIN
MIN EXPOSURE
MIN FLOW CHALLENGE
MIN SAMPLE
ML/MIN
ML/MIN
MM COVERSLIP
MM COVERSLIP
MODULATION
MODULATION
MODULATION
EC GROWTH MODULATION
MAPK PHOSPHATASE-1 MODULATION
MOLECULE CHANGE
MONOCLONAL PRIMARY ANTIBODY
MORPHOLOGIC CHANGE
MORPHOLOGIC CHANGE
MORPHOLOGIC CHANGE
MORPHOLOGIC CHANGE
MORPHOLOGIC EFFECT
MORPHOLOGIC RESPONSE
MORPHOLOGICAL CHANGE
MUSCLE PROLIFERATION
MUTUAL ORIENTATION
MUTUAL ORIENTATION
NM
NM
NEGATIVE CORRELATION
NITRIC OXIDE
NITRIC OXIDE SYNTHASE
NITRIC OXIDE SYNTHASE EXPRESSION
NM
NOCODAZOLE
NOCODAZOLE
NOCODAZOLE
NOCODAZOLE
NOCODAZOLE
NOCODAZOLE
NON-ELONGATED CELL
NORMAL PHYSIOLOGICAL RESPONSE
NOTED EXCEPTION
NUMEROUS STUDY
NUTRITIONAL STATUS
OCCURRING COMPONENT
OXIDANT DAMAGE
PH
PH
PANEL B
PANEL B
PANEL E
PARADOX
PEAK EXPRESSION
ENZYME NITRIC           OXIDE SYNTHASE PEAK EXPRESSION
PEPSTATIN
PERFUSATE
PERFUSION CHAMBER
PHENOTYPE
PHENYLMETHYLSULFONYL FLUORIDE
PHYSIOLOGIC ACTIVITY
PHYSIOLOGICALLY RELEVANT SUBENDOTHELIAL MATRIX
PLASTIC COVERSLIP
PLASTIC COVERSLIP
PLASTIC COVERSLIP
PLATE PERFUSION CHAMBER
PLATE PERFUSION CHAMBER
PLATELET ADHESION
PLATELET ADHESION
PLATELET
PLATELET
POLYPHENOL
POLYPHENOL
POLYPHENOL
POLYPHENOL
POLYPHENOLIC CONSTITUENT
POTENTIAL DAMAGE
PRECIPITOUS DECLINE
PREINCUBATION
PREPARATION
PRIMARY BPAEC PREPARATION
PREPARATION
PRIMARY BPAEC PREPARATION
PRIMARY BPAEC
PRIMARY BPAEC
PROBABILITY
PROTEASE INHIBITOR
APROTININ PROTEASE INHIBITOR
PROTEIN
PROTEIN
QUIN2-AM
QUIN2-AM
QUIN2-AM
QUIN2-AM
QUIN2-AM
RAT CAROTID ARTERIAL WALL
REACTIVE OXYGEN SPECIES
RECEPTOR
RECIRCULATING SYSTEM
RECTANGULAR SLAB
REDISTRIBUTION
FOCAL CONTACT REDISTRIBUTION
RELATIVE CHANGE
REORGANIZATION
ENDOTHELIAL CELL CYTOSKELETON REORGANIZATION
REPEATED FREEZE-THAW CYCLE
REPRESENTATIVE FIELD SCREEN CAPTURE
REPRESENTATIVE MICROSCOPIC FIELD
REPRESENTATIVE PICTURE
RESISTED DETACHMENT
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL FURTHER INSIGHT
RESVERATROL SIZE
RESVERATROL ACT
RESVERATROL DEPENDED
RESVERATROL INDUCED SIGNIFICANT CELLULAR
RESVERATROL TREATMENT
RESVERATROL TREATMENT
RESVERATROL-ELICITED MORPHOLOGICAL CHANGE
RESVERATROL-INDUCED CELLULAR PROPERTY
RESVERATROL-INDUCED MORPHOLOGCIAL CHANGE
RESVERATROL-MEDIATED ENDOTHELIAL SHAPE CHANGE
RESVERATROL-TREATED BPAEC
RESVERATROL-TREATED BPAEC
RESVERATROL-TREATED BPAEC
RESVERATROL-TREATED CELL
RESVERATROL-TREATED CELL
RETINOID
RHODAMINE-CONJUGATED PHALLOIDIN
RHODAMINE-PHALLOIDIN
RHODAMINE-PHALLOIDIN
RHODAMINE-PHALLOIDIN
RHODAMINE-PHALLOIDIN
ROLLER PERISTALTIC
SECONDARY ANTIBODY
SELECTIVE INHIBITOR
SELECTIVE INHIBITOR
SELECTIVE SIGNALING PATHWAY INHIBITOR
SHAPE CHANGE
SHEAR-SPECIFIC TRANSCRIPTION FACTOR
SIGNALING INHIBITOR
STATISTIC EVENT
STELLAR
STOCK SOLUTION
STOCK SOLUTION
STRESS CONDITION
STRESS FIBER
SUBENDOTHELIAL MATRIX
SUBENDOTHELIAL MATRIX COMPONENT
SUBENDOTHELIAL MATRIX COMPONENT
SUBSET
SUCROSE
SUSTAINED INCREASE
TARGETING SITE
THROMBOTIC PLUG
TIME POINT
TIME POINT
TORTUOUS PROCESS
TORTUOUS PROJECTION
TOTAL ERK1
TOTAL ERK1
TOTAL ERK1
TOTAL CELL
TRANS-RESVERATROL
TRI-HYDROXY STILBENE
TYROSINE KINASE ACTIVITY
TYROSINE KINASE ACTIVITY CHANGE
TYROSINE KINAS
TYROSINE KINAS
UPRIGHTED-STAGED MICROSCOPE
VASCULAR COMPONENT
VASCULAR ENDOTHELIUM
VASCULAR ENDOTHELIUM
VASCULATURE
VASODILATION
VEHICLE
ΜM
ΜM
ΜM
ΜM
ΜM
ΜM RESVERATROL
ΜM RESVERATROL
ΜM RESVERATROL
ΜM RESVERATROL
ΜM RESVERATROL-TREATED BPAEC
ΜM RESVERATROL-TREATED CELL
ΜM RESVERATROL-TREATED CELL
ΜG
ΜG/ML
ΜL
ΜL TB
RHODAMINE-PHALLOIDIN ΜL
CHD
MKP-1
REACTIVE OXYGEN           SPECIES
ROS
NO
ENZYME NITRIC           OXIDE SYNTHASE
ENOS
MINIMAL ESSENTIAL           MEDIUM
MEM
DITHIOTHREITOL
DTT
COVERSLIP
confocal microscope
CONFOCAL
CYTOSKELETON
GROWTH
interactions
INTEGRIN COMPLEX
INHIBITOR
INHIBITOR STUDY
INHIBITOR
oxidation
kinase
pathways
detachment
treatments
treatments
changes
STOCK
radiation
microfilaments
BPAEC
BPAEC
adhesion
CONSUMPTION
PHOSPHATASE-CONJUGATED IGG
agents
FLOW
ARTERIAL FLOW
FLOW CHALLENGE
ARTERIAL FLOW
ARTERIAL FLOW
ARTERIAL FLOW
CATHETER INJURY
barriers
GROWTH
GROWTH
CELLULAR BLOOD
heterogeneity
PHENOTYPE
PHENOTYPE
PHENOTYPE
properties
APPEARANCE
COLLAGEN-INDUCED AGGREGATION
effects
reactions
CONFOCAL MICROSCOPY
controls
controls
controls
controls
controls
STIMULATION
rearrangement
RESVERATROL
MAIN INTRAPULMONARY ARTERY
INTRAPULMONARY ARTERY
SPECIFICITY PHOSPHASE
ENOS
expressions
ENOS
expressions
shapes
endothelial
CELL CYTOSKELETON
ENDOTHELIAL CELL
CELL DAMAGE
ENDOTHELIAL CELL
CELL INTERACTION
ENDOTHELIAL CELL
ENDOTHELIAL CELL
cell monolayers
ENDOTHELIAL CELL
CELL SHAPE
ENDOTHELIAL CELL
CELL SHAPE
ENDOTHELIAL CELL SHAPE
ENDOTHELIAL CELL
injury
ILLUMINATION ATTACHMENT
BOVINE SERUM
FLOW
FLOW
FOCAL CONTACT ADHESION
FOCAL CONTACT
alterations
MICROTUBULE NETWORK
genes
expressions
EC
GROWTH
ARREST
GROWTH
inhibition
H
H
PEROXIDASE-CONJUGATED IGG
RESPONSE GENE PRODUCT
gene product
ENOS EXPRESSION
ENOS
ENOS EXPRESSION
ENOS
VALVE
relationships
MG(OAC)
DITHIOTHREITOL
K
metabolic functions
MIN
exposures
MIN
FLOW CHALLENGE
MIN
changes
changes
effects
responses
proliferation
orientation
orientation
correlations
NITRIC OXIDE
OXIDE SYNTHASE
NITRIC OXIDE SYNTHASE
NITRIC OXIDE
OXIDE SYNTHASE EXPRESSION
SYNTHASE EXPRESSION
synthase
NON-ELONGATED
PHYSIOLOGICAL RESPONSE
EXCEPTION
DAMAGE
B
B
ES
peaks
expressions
adhesion
adhesion
DAMAGE
DECLINE
BPAEC
BPAEC
CAROTID ARTERIAL WALL
REACTIVE OXYGEN
MICROSCOPIC FIELD
detachment
treatments
treatments
MORPHOLOGICAL CHANGE
ENDOTHELIAL SHAPE CHANGE
SHAPE CHANGE
RESVERATROL-TREATED
BPAEC
RESVERATROL-TREATED
BPAEC
RESVERATROL-TREATED
BPAEC
RESVERATROL-TREATED
RESVERATROL-TREATED
phalloidin
rollers
peristaltic
selective signaling pathway
shapes
changes
SHEAR-SPECIFIC TRANSCRIPTION
tfs
statistics
STOCK
STOCK
stress
stress
SUBENDOTHELIAL MATRIX
SUBENDOTHELIAL MATRIX
increases
PLUG
times
times
ERK1
ERK1
ERK1
stilbene
KINASE ACTIVITY
TYROSINE KINASE ACTIVITY
tyrosine
tyrosine
ENDOTHELIUM
ENDOTHELIUM
RESVERATROL
RESVERATROL
RESVERATROL
RESVERATROL
ΜM RESVERATROL-TREATED
RESVERATROL-TREATED BPAEC
RESVERATROL-TREATED
ΜM RESVERATROL-TREATED
RESVERATROL-TREATED
ΜM RESVERATROL-TREATED
RESVERATROL-TREATED
